Education
About Us
Working with TipRanks
Follow Us
Adaptimmune Therapeutics (ADAP)
NASDAQ:ADAP
Technical Sentiment
Overall Consensus
Neutral
10Bullish
4Neutral
8Bearish
Technical Analysis Consensus
Sell
2Bullish
4Neutral
4Bearish
Moving Average Consensus
Buy
8Bullish
0Neutral
4Bearish
Adaptimmune Therapeutics’s (ADAP) Moving Averages Convergence Divergence (MACD) indicator is <0.01, suggesting Adaptimmune Therapeutics is a Sell.
Adaptimmune Therapeutics’s (ADAP) 20-Day exponential moving average is 0.27, while Adaptimmune Therapeutics’s (ADAP) share price is $0.29, making it a Buy.
Adaptimmune Therapeutics’s (ADAP) 50-Day exponential moving average is 0.27, while Adaptimmune Therapeutics’s (ADAP) share price is $0.29, making it a Buy.
Adaptimmune Therapeutics (ADAP) Pivot Points
Classic
0.25
0.26
0.26
0.27
0.28
0.29
0.29
Fibonacci
0.26
0.26
0.27
0.27
0.28
0.28
0.29
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.
Adaptimmune Therapeutics (ADAP) Moving Averages
MA5
0.28Buy
0.28Buy
MA10
0.28Buy
0.27Buy
MA20
0.26Buy
0.27Buy
MA50
0.27Buy
0.27Buy
MA100
0.29Sell
0.33Sell
MA200
0.48Sell
0.53Sell
Adaptimmune Therapeutics’s (ADAP) 10-Day exponential moving average is 0.27, while Adaptimmune Therapeutics’s (ADAP) share price is $0.29, making it a Buy.
Adaptimmune Therapeutics’s (ADAP) 100-Day exponential moving average is 0.33, while Adaptimmune Therapeutics’s (ADAP) share price is $0.29, making it a Sell.
Adaptimmune Therapeutics’s (ADAP) stock price is $0.29 and Adaptimmune Therapeutics’s (ADAP) 50-day simple moving average is 0.27, creating a Buy signal.
Adaptimmune Therapeutics’s (ADAP) stock price is $0.29 and Adaptimmune Therapeutics’s (ADAP) 100-day simple moving average is 0.29, creating a Sell signal.
Adaptimmune Therapeutics’s (ADAP) stock price is $0.29 and Adaptimmune Therapeutics’s (ADAP) 200-day simple moving average is 0.48, creating a Sell signal.
Adaptimmune Therapeutics (ADAP) Technical Indicators
RSI (14)
60.35
Neutral
STOCH (9,6)
67.15
Neutral
STOCHRSI (14)
83.16
Sell
MACD (12,26)
<0.01
Sell
ADX (14)
22.70
Neutral
Williams %R
-10.71
Sell
CCI (14)
107.65
Sell
ATR (14)
0.02
-
Ultimate Oscillator
54.65
Neutral
ROC
20.83
Buy
Adaptimmune Therapeutics’s (ADAP) Relative Strength Index (RSI) is 60.35, creating a Neutral signal.
Adaptimmune Therapeutics’s (ADAP) Trend Strength Indicator (ADX) is 22.70, creating a Neutral signal.
Adaptimmune Therapeutics’s (ADAP) Commodity Channel Index (CCI) is 107.65, creating a Sell signal.
Adaptimmune Therapeutics’s (ADAP) Price Rate of Change (ROC) is 20.83, creating a Buy signal.
FAQ
Is ADAP a Buy, Hold, or Sell?
Based on ADAP’s technical indicators, ADAP is a Hold.
What is ADAP’s RSI (14)?
ADAP’s RSI (14) is 60.35, which suggests ADAP is a Neutral.
What is ADAP’s MACD?
ADAP’s MACD is <0.01, which suggests ADAP is a Sell.
What is ADAP’s 5-day moving average?
ADAP’s 5-day moving average is 0.28, which suggests ADAP is a Buy.
What is ADAP’s 20-day moving average?
ADAP 20-day moving average is 0.26, which suggests ADAP is a Buy.
What is ADAP’s 50-day moving average?
ADAP’s 50-day moving average is 0.27, which suggests ADAP is a Buy.
What is ADAP’s 200-day moving average?
ADAP’s 200-day moving average is 0.48, which suggests ADAP is a Sell.
What is ADAP’s Williams % R (14)?
ADAP’s Williams % R (14) is -10.71, which suggests ADAP is a Sell.
What is ADAP’s CCI (14)?
ADAP’s CCI (14) is 107.65, which suggests ADAP is a Sell.